Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jordan Karlitz to Humans

This is a "connection" page, showing publications Jordan Karlitz has written about Humans.

 
Connection Strength
 
 
 
0.455
 
  1. Montminy EM, Zhou M, Edelson JC, Karlitz JJ. Stage-Stratified Incidence Rates of Colorectal Adenocarcinoma Among Patients Aged 46 to 49 in the United States. JAMA Netw Open. 2024 03 04; 7(3):e241848.
    View in: PubMed
    Score: 0.023
  2. Montminy EM, Zhou M, Long C, Wani S, Patel SG, Karlitz JJ. Impact of Carcinoid and Appendiceal Site Inclusion on Early Onset Colon Cancer Incidence Rate Analysis in the United States. Clin Gastroenterol Hepatol. 2023 10; 21(11):2972-2974.e1.
    View in: PubMed
    Score: 0.021
  3. Montminy EM, Zhou M, Maniscalco L, Heda R, Kim MK, Patel SG, Wu XC, Itzkowitz SH, Karlitz JJ. Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):334-341.
    View in: PubMed
    Score: 0.020
  4. Karlitz JJ, Fendrick AM, Bhatt J, Coronado GD, Jeyakumar S, Smith NJ, Plescia M, Brooks D, Limburg P, Lieberman D. Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population. Popul Health Manag. 2022 06; 25(3):343-351.
    View in: PubMed
    Score: 0.020
  5. Montminy EM, Zhou M, Maniscalco L, Penrose H, Yen T, Patel SG, Wu XC, Karlitz JJ. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017. JAMA Netw Open. 2021 11 01; 4(11):e2130433.
    View in: PubMed
    Score: 0.020
  6. Karlitz JJ, Phillips A, Sorrells KS, Rao S. Genetic Analysis of Archived Tumor Specimens for Hereditary Colorectal Cancer Syndromes in the Cajuns of Louisiana, a US Founder Population. Clin Transl Gastroenterol. 2021 09 21; 12(9):e00392.
    View in: PubMed
    Score: 0.019
  7. Shah ED, Amann ST, Karlitz JJ. Response to Koulaouzidis, et al. Am J Gastroenterol. 2021 05 01; 116(5):1089.
    View in: PubMed
    Score: 0.019
  8. Shah ED, Amann ST, Karlitz JJ. Response to Tang, et al. Am J Gastroenterol. 2021 05 01; 116(5):1087-1088.
    View in: PubMed
    Score: 0.019
  9. Karlitz JJ, Montminy EM, Itzkowitz SH. Adenocarcinomas, as Opposed to Carcinoids, Are Primarily Driving Increases in Early-Onset Colorectal Cancer Rates. Gastroenterology. 2021 11; 161(5):1723-1724.
    View in: PubMed
    Score: 0.019
  10. Adviento B, Conner M, Sarkisian A, Walano N, Andersson H, Karlitz J. Feasibility of Utilizing PREMM Score for Lynch Syndrome Identification in an Urban, Minority Patient Population. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211020973.
    View in: PubMed
    Score: 0.018
  11. Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States. Ann Intern Med. 2021 02; 174(2):157-166.
    View in: PubMed
    Score: 0.018
  12. Montminy EM, Jang A, Conner M, Karlitz JJ. Screening for Colorectal Cancer. Med Clin North Am. 2020 Nov; 104(6):1023-1036.
    View in: PubMed
    Score: 0.018
  13. Abualkhair WH, Zhou M, Ochoa CO, Lacayo L, Murphy C, Wu XC, Karlitz JJ. Geographic and intra-racial disparities in early-onset colorectal cancer in the SEER 18 registries of the United States. Cancer Med. 2020 12; 9(23):9150-9159.
    View in: PubMed
    Score: 0.018
  14. Shah ED, Amann ST, Karlitz JJ. The Time Is Now: A Guide to Sustainable Telemedicine During COVID-19 and Beyond. Am J Gastroenterol. 2020 09; 115(9):1371-1375.
    View in: PubMed
    Score: 0.018
  15. Molmenti CL, Kolb JM, Karlitz JJ. Advanced Colorectal Polyps on Colonoscopy: A Trigger for Earlier Screening of Family Members. Am J Gastroenterol. 2020 03; 115(3):311-314.
    View in: PubMed
    Score: 0.017
  16. Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ. Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age. JAMA Netw Open. 2020 01 03; 3(1):e1920407.
    View in: PubMed
    Score: 0.017
  17. Noll A, J Parekh P, Zhou M, Weber TK, Ahnen D, Wu XC, Karlitz JJ. Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey?Study. Clin Transl Gastroenterol. 2018 09 20; 9(9):185.
    View in: PubMed
    Score: 0.016
  18. Karlitz JJ, Oliphant AB, Greenwald DA, Pochapin MB. The American College of Gastroenterology and the 80% by 2018 Colorectal Cancer Initiative: A Multifaceted Approach to Maximize Screening Rates. Am J Gastroenterol. 2017 Sep; 112(9):1360-1362.
    View in: PubMed
    Score: 0.015
  19. Noll A, Parekh PJ, Karlitz JJ. Diagnosis of Lynch syndrome before colorectal resection: does it matter? Tech Coloproctol. 2016 Apr; 20(4):203-5.
    View in: PubMed
    Score: 0.013
  20. Karlitz JJ, Hsieh MC, Liu Y, Blanton C, Schmidt B, Jessup JM, Wu XC, Chen VW. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients =50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery. Am J Gastroenterol. 2015 Jul; 110(7):948-55.
    View in: PubMed
    Score: 0.012
  21. Karlitz J, Provenzale D. Invited comment on Warrier et al: hereditary colorectal cancer screening and management practices by colorectal surgeons. Tech Coloproctol. 2014 Mar; 18(3):313-4.
    View in: PubMed
    Score: 0.011
  22. Karlitz JJ, Li ST, Holman RP, Rice MC. EBV-associated colitis mimicking IBD in an immunocompetent individual. Nat Rev Gastroenterol Hepatol. 2011 Jan; 8(1):50-4.
    View in: PubMed
    Score: 0.009
  23. Karlitz JJ. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med. 2009 Jun 02; 150(11):816; author reply 819-20.
    View in: PubMed
    Score: 0.008
  24. Karlitz JJ, Tepler IA, Tanaka KE. Endometriosis with colonic wall invasion. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):A30.
    View in: PubMed
    Score: 0.007
  25. Greene M, Pew T, Ozbay AB, Rinc?n L?pez JV, Brooks D, Karlitz J, Duarte M. Impact of Spanish Language Outreach on Multi-Target Stool DNA Test Adherence in a Federally Qualified Health Center in the United States. Cancer Control. 2025 Jan-Dec; 32:10732748251343334.
    View in: PubMed
    Score: 0.006
  26. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. Comparison of trends in early-onset colorectal cancer in North America and Europe - Authors' reply. Lancet Gastroenterol Hepatol. 2022 06; 7(6):506.
    View in: PubMed
    Score: 0.005
  27. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022 03; 7(3):262-274.
    View in: PubMed
    Score: 0.005
  28. Yen T, Scolaro J, Montminy E, Karlitz JJ, Wani S, Patel SG. Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50. Clin Gastroenterol Hepatol. 2023 03; 21(3):827-829.e3.
    View in: PubMed
    Score: 0.005
  29. Zhou M, Thompson TD, Lin HY, Chen VW, Karlitz JJ, Fontham ETH, Theall KP, Zhang L, Hsieh MC, Pollack LA, Wu XC. Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients. Clin Colorectal Cancer. 2022 06; 21(2):e62-e75.
    View in: PubMed
    Score: 0.005
  30. Fendrick AM, Fisher DA, Saoud L, Ozbay AB, Karlitz JJ, Limburg PJ. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Cancer Prev Res (Phila). 2021 09; 14(9):845-850.
    View in: PubMed
    Score: 0.005
  31. Fisher DA, Karlitz JJ, Jeyakumar S, Smith N, Limburg P, Lieberman D, Fendrick AM. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population. J Med Econ. 2021 Jan-Dec; 24(1):654-664.
    View in: PubMed
    Score: 0.005
  32. Dwyer AJ, Murphy CC, Boland CR, Garcia R, Hampel H, Limburg P, Lowery J, Zauber AG, Waring S, Worrall S, Perea J, Siegel R, Lee J, Molmenti C, Sears CL, Buckhaults P, Hayes R, Hussan H, de Miranda N, Palles C, Diaz L, Song M, Cercek A, Lieu CH, Patel SG, Karlitz JJ, Cao Y, Demb J, Blatchford P, Risendal B, Staples ES, Wali A, Daschner P, Loomans-Kropp H, Flores R, Levell CL, Wehling K, Martin J, Pesmen C, Kuchar V, Soisson R, Davis A, Ahnen D. A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer. Gastroenterology. 2019 08; 157(2):280-288.
    View in: PubMed
    Score: 0.004
  33. Montminy EM, Karlitz JJ, Landreneau SW. Progress of colorectal cancer screening in United States: Past achievements and future challenges. Prev Med. 2019 03; 120:78-84.
    View in: PubMed
    Score: 0.004
  34. Charlton ME, Kahl AR, Greenbaum AA, Karlitz JJ, Lin C, Lynch CF, Chen VW. KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010-2013. J Natl Compr Canc Netw. 2017 12; 15(12):1484-1493.
    View in: PubMed
    Score: 0.004
  35. Charlton ME, Karlitz JJ, Schlichting JA, Chen VW, Lynch CF. Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study. Am J Clin Oncol. 2017 Oct; 40(5):498-506.
    View in: PubMed
    Score: 0.004
  36. Chen VW, Hsieh MC, Charlton ME, Ruiz BA, Karlitz J, Altekruse SF, Ries LA, Jessup JM. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. Cancer. 2014 Dec 01; 120 Suppl 23:3793-806.
    View in: PubMed
    Score: 0.003
  37. Gupta MK, Karlitz JJ, Raines DL, Florman SS, Lopez FA. Clinical case of the month. Heterotopic pancreas. J La State Med Soc. 2010 Nov-Dec; 162(6):310-3.
    View in: PubMed
    Score: 0.002
  38. Feuerstadt P, Bunim AL, Garcia H, Karlitz JJ, Massoumi H, Thosani AJ, Pellecchia A, Wolkoff AW, Gaglio PJ, Reinus JF. Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients. Hepatology. 2010 Apr; 51(4):1137-43.
    View in: PubMed
    Score: 0.002
  39. Keller CE, Gamboa ET, Hays AP, Karlitz J, Lowe G, Green PH, Bhagat G. Fatal CNS vasculopathy in a patient with refractory celiac disease and lymph node cavitation. Virchows Arch. 2006 Feb; 448(2):209-13.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)